000			01188 a2200313 4500
005			20250516031422.0
264		0	_c20111005
008			201110s 0 0 eng d
022			_a1879-016X
024	7		_a10.1016/j.pharmthera.2011.03.011 _2doi
040			_aNLM _beng _cNLM
100	1		_aZhang, Lei
245	0	0	_aThe neuropeptide Y system: pathophysiological and therapeutic implications in obesity and cancer. _h[electronic resource]
260			_bPharmacology & therapeutics _cJul 2011
300			_a91-113 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650	0	4	_aAnimals
650	0	4	_aEnergy Intake _xdrug effects
650	0	4	_aEnergy Metabolism _xdrug effects
650	0	4	_aHumans
650	0	4	_aMolecular Targeted Therapy _xmethods
650	0	4	_aNeoplasms _xdrug therapy
650	0	4	_aNeuropeptide Y _xantagonists & inhibitors
650	0	4	_aObesity _xdrug therapy
700	1		_aBijker, Martijn S
700	1		_aHerzog, Herbert
773	0		_tPharmacology & therapeutics _gvol. 131 _gno. 1 _gp. 91-113
856	4	0	_uhttps://doi.org/10.1016/j.pharmthera.2011.03.011 _zAvailable from publisher's website
999			_c20708845 _d20708845